Skip to main content

Amgen news in 2026: 20 dated events

The latest Amgen event on this page is dated Sep 16, 2026. prnewswire.com reported: Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2...

Public (AMGN)Biotechnology Research10,000+ employeesamgen.comLinkedIn

Dated events
24
Last 90 days
10
Latest
Sep 16, 2026

News · latest 10

Latest Amgen news

  1. In development
    Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2...Amgen is developing Dazodalibep, an investigational biologic targeting the CD40-CD40L pathway for Sjögren's disease.
  2. Integration
  3. In development
    Cholesterol drug setback casts doubt over multibillion-dollar raceAmgen is developing a drug, olpasiran, to lower Lp(a) cholesterol as a rival treatment to Novartis's pelacarsen.
  4. Partnership
  5. In development
  6. Revenue
    Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes TherapeuticsAmgen's product Imdelltra reported revenue of more than USD 600 million in 2025.
  7. New location
    Amgen (AMGN) Opens New Science And Innovation Center In HyderabadAmgen has opened a new Science and Innovation Center in Genome Valley, Hyderabad, to expand its global research and development presence.
  8. Revenue
    AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTSAmgen reported total product sales of $9.537 billion for the second quarter of 2026, a 9% increase year-over-year.
  9. Partnership
    Amgen (AMGN) Partners With MrBeast To Fund Pediatric Cancer Research And Reach 500 Million SubscribersAmgen has partnered with YouTube personality MrBeast on a video campaign to raise awareness and funding for pediatric cancer research.
  10. In development

Showing 10 of 24 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Amgen with the Signal API

One POST /v1/companies/enrich call with amgen.com returns Amgen news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"amgen.com","signal_types":["news"],"limit":20}'

Same industry

Questions about Amgen news

What is the latest news on Amgen?
The newest event on this page is dated Sep 16, 2026. prnewswire.com reported: Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2.... This page lists 24 dated events for Amgen, each with a source link.
What is going on with Amgen?
The 10 latest events on this page cover in development (4), integration (1), partnership (2), revenue (2) and new location (1). The newest: Sep 16, 2026: Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2... (prnewswire.com).

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →